ResolveARA-290 (Cibinetide)
Innate repair receptor agonist.
About
What it is
ARA-290 activates the innate repair receptor — a tissue-protective pathway separate from the erythropoiesis pathway. It reduces inflammation, protects nerves, and supports tissue repair without affecting red blood cell production.
How it works
ARA-290 binds to the innate repair receptor (IRR), a heterodimer of the erythropoietin receptor and the beta common receptor. Unlike erythropoietin itself, ARA-290 doesn't stimulate red blood cell production — it activates tissue-protective and anti-inflammatory pathways specifically.
Benefits
Who it's for
What to expect
Week 1–2
Anti-inflammatory effects begin. Pain may decrease.
Week 3–4
Tissue repair signaling continues. Neuropathic symptoms improve.
Week 6–8
Sustained pain reduction and tissue protection.
Safety & tolerability
ARA-290 has been studied in clinical trials for sarcoidosis and neuropathic pain. Its tissue-protective mechanism is separate from erythropoiesis, avoiding blood-related side effects. Our care team monitors your inflammatory markers and pain response.
How we compound
Single-source API
Every peptide is sourced from one vetted pharmaceutical-grade supplier — no blending from multiple sources.
Third-party tested
Independent labs verify purity, potency, sterility, and endotoxin levels before any batch is released.
Care team reviewed
A real person reviews your profile, your protocol, and your progress. Not an algorithm.
Recovery & Healing
ResolveARA-290 (Cibinetide)
Every protocol is reviewed by our care team before it ships. Questions? Learn more
$149/mo
